AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

89,900

Employees89,900

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1992

Founded1992

Employees

89,900

Employees89,900

AZN Key Statistics

Market cap

225.58B

Market cap225.58B

Price-Earnings ratio

32.05

Price-Earnings ratio32.05

Dividend yield

2.00%

Dividend yield2.00%

Average volume

5.79M

Average volume5.79M

High today

$73.06

High today$73.06

Low today

$71.85

Low today$71.85

Open price

$72.01

Open price$72.01

Volume

5.34M

Volume5.34M

52 Week high

$87.68

52 Week high$87.68

52 Week low

$60.47

52 Week low$60.47

AZN News

TipRanks 4h

AstraZeneca Poised for Strong Growth with Strategic Market Positioning and Robust Pipeline

Sarita Kapila, an analyst from Morgan Stanley, maintained the Buy rating on AstraZeneca (AZN – Research Report). The associated price target is p14,500.00. Max...

TipRanks 2d

AstraZeneca: Strong Growth Potential and Market Position Underpin Buy Rating

Goldman Sachs analyst Ronald Keung has reiterated their bullish stance on AZN stock, giving a Buy rating on February 6. Maximize Your Portfolio with Data Drive...

Financial Times 5d

The inside story of Britain’s failure to clinch £450mn AstraZeneca deal

Print this page Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In late November 2023 AstraZeneca’s chief executive P...

Analyst ratings

82%

of 33 ratings

Buy

81.8%

Hold

18.2%

Sell

More AZN News

The Motley Fool 6d

Why AstraZeneca Topped the Market on Thursday

A fresh earnings release was the news development powering AstraZeneca's (AZN 2.01%) share price higher on Thursday. Investors were clearly impressed by the pha...

Benzinga 6d

AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China

On Thursday, AstraZeneca Plc AZN reported fourth-quarter sales of $14.89 billion, up 18% year over year (+19% at constant currency), beating the consensus of $1...

Seeking Alpha 6d

AstraZeneca gains as Q4 results clear China overhang

AstraZeneca (NASDAQ:AZN) shares gained in European trading on Thursday after the Anglo-Swedish drugmaker reported better-than-expected Q4 2024 results and addre...